These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 11779756)

  • 1. Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis.
    Danieli MG; Malcangi G; Palmieri C; Logullo F; Salvi A; Piani M; Danieli G
    Ann Rheum Dis; 2002 Jan; 61(1):37-41. PubMed ID: 11779756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunosuppressant treatment in refractory myositis. Our experience].
    Danieli MG; Spalletta C; Moretti R; Calabrese V; Marchetti A; Gabrielli A; Logullo F
    Recenti Prog Med; 2009 Oct; 100(10):451-7. PubMed ID: 20030167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporin A in the treatment of refractory adult polymyositis/dermatomyositis: population based experience in 6 patients and literature review.
    Qushmaq KA; Chalmers A; Esdaile JM
    J Rheumatol; 2000 Dec; 27(12):2855-9. PubMed ID: 11128676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of polymyositis and dermatomyositis.
    Kaye SA; Isenberg DA
    Br J Hosp Med; 1994 Nov 2-15; 52(9):463-8. PubMed ID: 7874361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Current therapy for polymyositis and dermatomyositis].
    Chérin P
    Rev Med Interne; 2008 Jun; 29 Spec No 2():9-14. PubMed ID: 18927983
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients.
    Cherin P; Herson S; Wechsler B; Piette JC; Bletry O; Coutellier A; Ziza JM; Godeau P
    Am J Med; 1991 Aug; 91(2):162-8. PubMed ID: 1714235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous immunoglobulin therapy for refractory interstitial lung disease associated with polymyositis/dermatomyositis.
    Suzuki Y; Hayakawa H; Miwa S; Shirai M; Fujii M; Gemma H; Suda T; Chida K
    Lung; 2009; 187(3):201-6. PubMed ID: 19387736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulin therapy in adult patients with polymyositis/dermatomyositis: a systematic literature review.
    Wang DX; Shu XM; Tian XL; Chen F; Zu N; Ma L; Wang GC
    Clin Rheumatol; 2012 May; 31(5):801-6. PubMed ID: 22274797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulins for steroid-refractory esophageal involvement related to polymyositis and dermatomyositis: a series of 73 patients.
    Marie I; Menard JF; Hatron PY; Hachulla E; Mouthon L; Tiev K; Ducrotte P; Cherin P
    Arthritis Care Res (Hoboken); 2010 Dec; 62(12):1748-55. PubMed ID: 20722047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Results and long-term followup of intravenous immunoglobulin infusions in chronic, refractory polymyositis: an open study with thirty-five adult patients.
    Cherin P; Pelletier S; Teixeira A; Laforet P; Genereau T; Simon A; Maisonobe T; Eymard B; Herson S
    Arthritis Rheum; 2002 Feb; 46(2):467-74. PubMed ID: 11840450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study.
    Danieli MG; Gambini S; Pettinari L; Logullo F; Veronesi G; Gabrielli A
    Autoimmun Rev; 2014 Oct; 13(10):1048-54. PubMed ID: 25183232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients.
    Cherin P; Piette JC; Wechsler B; Bletry O; Ziza JM; Laraki R; Godeau P; Herson S
    J Rheumatol; 1994 Jun; 21(6):1092-7. PubMed ID: 7932419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoglobulins or plasma exchange? New treatment methods in polymyositis and dermatomyositis: plasma exchange and intravenous immunoglobulins].
    Chérin P; Herson S
    Ann Med Interne (Paris); 1993; 144(8):521-5. PubMed ID: 8179241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dermatomyositis and polymyositis: clinical aspects and treatment].
    Hachulla E
    Ann Med Interne (Paris); 2001 Nov; 152(7):455-64. PubMed ID: 11965087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis.
    Danieli MG; Calcabrini L; Calabrese V; Marchetti A; Logullo F; Gabrielli A
    Autoimmun Rev; 2009 Dec; 9(2):124-7. PubMed ID: 19386287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nation-wide survey for the treatment with cyclosporin A of interstitial pneumonia associated with collagen diseases].
    Harigai M; Hara M; Kamatani N; Kashiwazaki S
    Ryumachi; 1999 Dec; 39(6):819-28. PubMed ID: 10695405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pilot study: use of fludarabine for refractory dermatomyositis and polymyositis, and examination of endpoint measures.
    Adams EM; Pucino F; Yarboro C; Hicks JE; Thornton B; McGarvey C; Sonies BC; Bartlett ML; Villalba ML; Fleisher T; Plotz PH
    J Rheumatol; 1999 Feb; 26(2):352-60. PubMed ID: 9972969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic advances in myositis.
    Aggarwal R; Oddis CV
    Curr Opin Rheumatol; 2012 Nov; 24(6):635-41. PubMed ID: 22955021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.